Obstetrics & Gynaecology · Ovarian Tumors (Benign, Malignant, Classification)

A 22-year-old woman undergoes right salpingo-oophorectomy for a 12 cm ovarian mass. Histology reveals a dysgerminoma confined to the right ovary with intact capsule (FIGO Stage IA). She strongly desires future fertility. What is the recommended adjuvant treatment?

  • A Bleomycin, Etoposide, Cisplatin (BEP) 3 cycles
  • B Carboplatin and Paclitaxel 6 cycles
  • C Pelvic radiotherapy to the residual ovary
  • D Observation only after complete staging
Correct answer: D. Observation only after complete staging

Explanation

Stage IA dysgerminoma treated by unilateral salpingo-oophorectomy with thorough surgical staging has a 5-year survival > 95% with surveillance alone. Adjuvant chemotherapy (BEP) is reserved for higher-stage disease. Radiotherapy is no longer preferred as it impairs fertility. Carboplatin-paclitaxel is used for epithelial ovarian cancer, not dysgerminoma.

Reference: Shaw's Textbook of Gynaecology, 17th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Ovarian Tumors (Benign, Malignant, Classification) MCQs

See all Ovarian Tumors (Benign, Malignant, Classification) MCQs →